GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (STU:TEHN) » Definitions » Total Liabilities

Avid Bioservices (STU:TEHN) Total Liabilities : €252.5 Mil (As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is Avid Bioservices Total Liabilities?

Avid Bioservices's Total Liabilities for the quarter that ended in Jan. 2024 was €252.5 Mil.

Avid Bioservices's quarterly Total Liabilities increased from Jul. 2023 (€227.57 Mil) to Oct. 2023 (€256.61 Mil) but then declined from Oct. 2023 (€256.61 Mil) to Jan. 2024 (€252.50 Mil).

Avid Bioservices's annual Total Liabilities increased from Apr. 2021 (€156.98 Mil) to Apr. 2022 (€236.42 Mil) and increased from Apr. 2022 (€236.42 Mil) to Apr. 2023 (€238.57 Mil).


Avid Bioservices Total Liabilities Historical Data

The historical data trend for Avid Bioservices's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Total Liabilities Chart

Avid Bioservices Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.54 60.47 156.98 236.42 238.57

Avid Bioservices Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 245.95 238.57 227.57 256.61 252.50

Avid Bioservices Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Avid Bioservices's Total Liabilities for the fiscal year that ended in Apr. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=67.223+(171.342+-2.8421709430404E-14
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=238.6

Total Liabilities=Total Assets (A: Apr. 2023 )-Total Equity (A: Apr. 2023 )
=411.361-172.797
=238.6

Avid Bioservices's Total Liabilities for the quarter that ended in Jan. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=204.61+(47.892+-7.105427357601E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=252.5

Total Liabilities=Total Assets (Q: Jan. 2024 )-Total Equity (Q: Jan. 2024 )
=417.898-165.396
=252.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avid Bioservices Total Liabilities Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices (STU:TEHN) Business Description

Traded in Other Exchanges
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Avid Bioservices (STU:TEHN) Headlines

No Headlines